Dose decision of HSK7653 oral immediate release tablets in specific populations clinical trials based on mechanistic physiologically-based pharmacokinetic model

药代动力学 基于生理学的药代动力学模型 医学 药理学 人口 体内 肾脏生理学 口服 糖尿病 内科学 排泄 肾功能 内分泌学 生物 生物技术 环境卫生
作者
Miao Zhang,Shu‐Dong Zhang,Zhiheng Yu,Xueting Yao,Zihan Lei,Pangke Yan,Nan Wu,Xu Wang,Qin Hu,Dongyang Liu
出处
期刊:European Journal of Pharmaceutical Sciences [Elsevier BV]
卷期号:189: 106553-106553 被引量:2
标识
DOI:10.1016/j.ejps.2023.106553
摘要

HSK7653, an oral dipeptidyl peptidase-4 inhibitor administered every 2 weeks, is a candidate for the treatment of type 2 diabetes mellitus. The major elimination pathway of HSK7653 in vivo is renal excretion, and hepatic metabolism and fecal excretion of unchanged compound contribute less to the systemic clearance of HSK7653. Considering the disposition characteristics and the potential indication population of HSK7653, evaluating the HSK7653 exposure in patients with renal impairment and geriatric populations is a prerequisite for bringing more benefits to the patients. Here, a PBPK model was developed based on in vitro experimental results, such as dissolution, permeability, and metabolism, and the in vivo renal clearance, to evaluate the effects of physiological factors and food on HSK7653 exposure in specific populations, including adult and elder individuals with renal impairment and geriatric populations. Simulation results showed that the AUC of HSK7653 increased by 46%, 82%, and 129% in adult patients with mild, moderate, and severe renal impairment, and by 56%, 78%, and 101% in patients aged 65-75, 75-85 and 85-95 years, respectively. The AUC increased in the range of 62%-83%, 98%-133%, and 153%-195% in elderly patients (65-95 years) with mild, moderate, and severe renal impairment, respectively. Moreover, two different absorption model development methods (dissolution profile method and the diffusion layer model method) predicted that food had no effect on the exposure of the same simulated population. Since the predicted AUC of HSK7653 at the 10 mg dose in various specific populations was still within the relatively flat results of the exposure-response analysis, the 10 mg dose of HSK7653 was first used to explore the exposure in the renal impairment population (CTR20221952).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
drew发布了新的文献求助10
1秒前
迟迟发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
小小富应助clientprogram采纳,获得30
2秒前
123完成签到,获得积分10
2秒前
抹茶夏天发布了新的文献求助10
2秒前
2秒前
年轻的从凝关注了科研通微信公众号
3秒前
3秒前
大糖糕僧发布了新的文献求助10
3秒前
刺猬发布了新的文献求助10
3秒前
妍妍完成签到,获得积分10
3秒前
英俊的铭应助彭a采纳,获得10
4秒前
4秒前
liuzhanyu发布了新的文献求助10
5秒前
pcr163应助ijn采纳,获得50
5秒前
暴富发布了新的文献求助10
5秒前
小小富应助clientprogram采纳,获得30
5秒前
6秒前
和谐雨竹发布了新的文献求助10
7秒前
wjx关闭了wjx文献求助
7秒前
qitan发布了新的文献求助10
7秒前
CipherSage应助清新的不凡采纳,获得10
8秒前
8秒前
bettyscu发布了新的文献求助10
8秒前
李健应助科研通管家采纳,获得10
8秒前
wy.he应助科研通管家采纳,获得20
8秒前
loong应助科研通管家采纳,获得10
9秒前
英俊的铭应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
JOY发布了新的文献求助10
9秒前
英姑应助科研通管家采纳,获得10
9秒前
柯一一应助科研通管家采纳,获得10
9秒前
情怀应助科研通管家采纳,获得10
9秒前
smottom应助科研通管家采纳,获得20
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974463
求助须知:如何正确求助?哪些是违规求助? 3518823
关于积分的说明 11196212
捐赠科研通 3255008
什么是DOI,文献DOI怎么找? 1797655
邀请新用户注册赠送积分活动 877052
科研通“疑难数据库(出版商)”最低求助积分说明 806130